Illumina, Inc. logo

Illumina, Inc. (ILMN)

Market Closed
11 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
99. 25
-0.8
-0.8%
$
15.96B Market Cap
- P/E Ratio
0% Div Yield
1,998,700 Volume
0.66 Eps
$ 100.05
Previous Close
Day Range
97.7 100.4
Year Range
68.7 156.66
Want to track ILMN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 22 days
Unveiling Illumina (ILMN) Q1 Outlook: Wall Street Estimates for Key Metrics

Unveiling Illumina (ILMN) Q1 Outlook: Wall Street Estimates for Key Metrics

Beyond analysts' top -and-bottom-line estimates for Illumina (ILMN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.

Zacks | 2 months ago
Illumina (ILMN) Earnings Expected to Grow: Should You Buy?

Illumina (ILMN) Earnings Expected to Grow: Should You Buy?

Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 2 months ago
Here's Why Illumina (ILMN) is a Strong Value Stock

Here's Why Illumina (ILMN) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 3 months ago
Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholders

Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholders

Keith Meister, Corvex Management's chief investment officer, will join Illumina's board starting March 28. He's no stranger to the world of biotech.

Cnbc | 3 months ago
Is Illumina Undervalued After An 83% Drop In Its Stock Price?

Is Illumina Undervalued After An 83% Drop In Its Stock Price?

The base and pessimistic DCF models implemented in this article suggest that Illumina is undervalued. Illumina expects to reach a growth rate in its revenues of 6%-9% CAGR by 2027. The DNA sequencing market is expected to grow by 14.90%-21.65% CAGR in the following ten years.

Seekingalpha | 3 months ago
Activist investor Keith Meister to join Illumina's board, WSJ reports

Activist investor Keith Meister to join Illumina's board, WSJ reports

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott Gottlieb will become chairman, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

Reuters | 3 months ago
Activist Investor Meister to Join Illumina's Board

Activist Investor Meister to Join Illumina's Board

Keith Meister's hedge fund Corvex Management has a 2.5% stake in the gene-sequencing machine maker.

Wsj | 3 months ago
Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain?

Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain?

ILMN-NashBio's AGD initiative achieves the milestone of completing 250,000 whole genomes.

Zacks | 3 months ago
Why Illumina (ILMN) is a Top Value Stock for the Long-Term

Why Illumina (ILMN) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 3 months ago
Illumina lowers outlook due to China sales ban, to cut $100 million in costs

Illumina lowers outlook due to China sales ban, to cut $100 million in costs

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban on imports of its genetic sequencing instruments.

Reuters | 4 months ago
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban

Beijing banned imports of Illumina's gene-sequencing machines in response to U.S. tariffs.

Wsj | 4 months ago
Illumina Stock Drops as China Bans Imports of Gene-Sequencing Technology

Illumina Stock Drops as China Bans Imports of Gene-Sequencing Technology

Illumina was placed on China's list of ‘unreliable entities' in February.

Barrons | 4 months ago
Loading...
Load More